Design and evaluation of a hypoallergenic peptide-based vaccine for Salsola kali allergy.

CONCLUSION: The designed vaccine can be considered as a promising candidate for therapeutic allergen-specific immunotherapy.
PMID: 30445308 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - November 13, 2018 Category: Allergy & Immunology Authors: Tabesh S, Fanuel S, Fazlollahi MR, Yekaninejad MS, Kardar GA, Razavi SA Tags: Int Immunopharmacol Source Type: research